Acorn Will Present CorCap Clinical Trial Update At ACC Meeting
This article was originally published in The Gray Sheet
Executive Summary
Acorn Cardiovascular expects to complete enrollment for a 300-patient, randomized trial of its CorCap cardiac support device for heart failure by July